Issue 3 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Robert Winn holds forth on big data, bench-to-community research—and being the only African American director of an NCI-designated cancer center

NCI increases funding for extramural research by $210M in FY2020; funds more than 125 additional competing awards

Turman named president of ACT for NIH, group credited with boosting research funding

In Brief

Al Benson named to new role in ECOG-ACRIN leadership

Karen Reckamp to head medical oncology at Cedars-Sinai

Dolores Hambardzumyan joins neurosurgery faculty at Mount Sinai

Douglas Hanahan, Ping-Chih Ho receive appointments at Ludwig Cancer Research

Northwell acquires Queens medical oncology practice

Clinical Roundup

Multimodal genomic analyses predict response to immunotherapy in NSCLC

Nanoparticle therapy offers potential new treatment for aggressive breast cancer

MEAL study: eating more veggies, fruits will not cure, stop prostate cancer

Drugs & Targets

FDA grants Rubraca Priority Review for advanced prostate cancer

FDA accepts BLA for Priority Review of Opdivo + Yervoy in first-line NSCLC

Concerto HealthAI collaborates with Pfizer, Janssen; launches eurekaHealth 3.0

Roche, Illumina collaborate to broaden patient access to genomic testing

Qiagen, Amgen collaborate on companion diagnostic development in NSCLC

NCI Trials

NCI Trials for Jan. 2020

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login